Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-31 @ 2:08 AM
Study NCT ID:
NCT03851432
Status:
UNKNOWN
Last Update Posted:
2020-07-16
First Post:
2019-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin
Sponsor:
Sihuan Pharmaceutical Holdings Group Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
5695-DIA-3002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None